Dexco Q3 2026 adjusted recurring pro forma EBITDA rises 38% year over year to R$ 783.63 million

Bitget2026/11/04 22:35

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Dexco’s third-quarter 2026 adjusted recurring pro forma EBITDA rose 38% year over year to BRL 783.63 million, including its LD Celulose share.
The recurring net loss narrowed 87% year over year to BRL 5.5 million.
Pro forma net revenue climbed 10% year over year to BRL 2.34 billion, primarily supported by the wood division.
Industrial restructuring includes closing the Recife sanitaryware plant and concentrating production in Jundiaí, supplemented by outsourced manufacturing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dexco SA published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Dexco Q3 2026 adjusted recurring pro forma EBITDA rises 38% year over year to R$ 783.63 million

You may also like

Crypto prices